(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






4 Result: Nasdaq:CELH

CarMax Q1 Beats; Stephens: Opportunity on Celsius, Hain Celestial, Sovos, SunOpta

June 23rd, 2023

Shares of CarMax, Inc. (NYSE: KMX) experienced a significant surge of over 5% in pre-market trading following the announcement of its better-than-expected first-quarter fiscal 2024 financial results.  The company reported earnings per share (. Read more

Key Analyst Ratings: PBA, CELH, ASM, EQIX, MKSI, and NDSN - Latest Updates

June 22nd, 2023

Pembina Pipeline Corporation (NYSE: PBA), a leading energy infrastructure company, received a favorable coverage initiation from Stifel with a Buy rating and a price target of $51.  Despite $PBA closing at $30.96 on Wednesday, the investment . Read more

Market Buzz: Semtech and 4D Molecular Making Waves, Celsius and Alkermes Get PT Boost

June 08th, 2023

Semtech Corporation (Nasdaq: SMTC) has delivered better-than-expected results in the first quarter of fiscal 2024, reporting earnings per share (EPS) of $0.02, surpassing the consensus estimate of a loss of $0.08 per share.  Looking ahead to . Read more

Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised

June 04th, 2023

Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients.  Acco. Read more

Load More Content